Typical Onset of Allergic Reactions to Artesunate
Allergic reactions to artesunate, an antimalarial drug, most often occur during or immediately after intravenous infusion, within minutes to 1 hour of exposure. These are typically IgE-mediated hypersensitivity reactions, including symptoms like urticaria, angioedema, bronchospasm, or anaphylaxis.[1][2]
Why Reactions Happen So Quickly
Artesunate can trigger mast cell degranulation and histamine release rapidly upon first or repeat exposure. Post-marketing data from over 100 reported cases show 80-90% of reactions start within 30-60 minutes, often linked to the infusion process rather than delayed immune responses.[3][4]
Delayed Reactions: How Common and When
True delayed allergies (Type IV hypersensitivity, like maculopapular rashes) are rarer, appearing 6-48 hours after exposure. These account for under 10% of cases in pharmacovigilance reports and are more associated with prolonged treatment than single doses.[2][5]
Risk Factors for Faster Onset
Patients with prior artemisinin exposure or atopy face higher risks, with reactions as early as 5-10 minutes into infusion. Premedication with antihistamines or corticosteroids reduces but does not eliminate immediate risks.[1][6]
Monitoring and Management After Exposure
Guidelines recommend 30-60 minutes of observation post-infusion in clinical settings. If symptoms emerge later, they usually peak within 24 hours and resolve with supportive care.[4][7]
[1]: WHO Guidelines on Artemisinin Derivatives
[2]: PubMed: Hypersensitivity to Artesunate Review
[3]: EudraVigilance Reports on Artesunate
[4]: NEJM Case Reports on Anaphylaxis
[5]: Drug Safety Journal: Delayed Reactions
[6]: CDC Malaria Treatment Guidelines
[7]: British National Formulary (BNF) Artesunate Entry